Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17028760 | 1.00 | GPR3 (0.38) | GPR3TAAR1RIPK1IDO1AOC3 | |
| SCHEMBL17028761 | 1.00 | GPR3 (0.38) | GPR3TAAR1RIPK1IDO1AOC3 | |
| SCHEMBL15994994 | 0.89 | RIPK1 (0.35) | GPR3RIPK1 | |
| SCHEMBL17749309 | 0.89 | RIPK1 (0.35) | GPR3RIPK1 | |
| SCHEMBL15994995 | 0.89 | RIPK1 (0.35) | GPR3RIPK1 | |
| SCHEMBL17028752 | 0.87 | NPC1 (0.38) | RIPK1MAOBLMNAALDH1A1 | |
| SCHEMBL30681392 | 0.87 | GPR3 (0.30) | GPR3 | |
| SCHEMBL2582230 | 0.86 | TAAR1 (0.40) | GPR3TAAR1RIPK1IDO1AOC3 | |
| SCHEMBL15820811 | 0.81 | IDO1 (0.37) | RIPK1IDO1MAOB | |
| SCHEMBL15820812 | 0.81 | IDO1 (0.37) | RIPK1IDO1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353163-A1 | 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES | Janssen Pharmaceutica, N.V. (BE) | 2018-08-01 | — | — | EP | disclosed |
| EP-3271355-A1 | BACE1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2018-01-24 | — | — | EP | disclosed |
| WO-2017050978-A1 | 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-30 | — | — | WO | disclosed |
| WO-2016150785-A1 | BACE1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2016-09-29 | — | — | WO | disclosed |
| WO-2011138293-A1 | 2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-11-10 | — | — | WO | disclosed |